The Eagles placed Hurts on injured reserve on Saturday, guaranteeing at least four games away from active duty. However, the latest medical information could extend his absence well beyond that initial four-game window, depending on how air travel, healing, and treatment progress. The team and Hurts’ camp have emphasized cautious, comprehensive medical care to protect long-term health and career longevity.
Hurts’ representative provided further context on the diagnosis, treatment plan, and expected timeline for return. In a public statement, agent Nicole Lynn confirmed that tests identified deep vein thrombosis and bilateral pulmonary emboli. She noted that Hurts is clinically stable and will be treated with blood thinners to address the clots. While this news is serious, Lynn described the prognosis as favorable, with an expectation of full recovery and no lasting effects on the player’s health or athletic capabilities once healing is complete.
The medical update also stated that Hurts will not participate in any contact activities, including football, during treatment. This restriction is a standard precaution with blood-clot diagnoses to prevent complications and ensure patient safety while anticoagulation therapy is underway. If the course of treatment extends for an extended period, the timeline for a potential return could stretch into months, reducing the likelihood of Hurts taking the field again in the current season.
From a team perspective, the Eagles must navigate life without their starting quarterback while balancing immediate on-field needs with long-term health considerations. Prior to the illness, Hurts had been productive through five games, compiling 933 passing yards with eight touchdowns and three interceptions. His absence necessitates a reshuffled offense and an elevated role for backup quarterback in the interim.
The immediate plan for Philadelphia centers on stability and risk mitigation. Tanner McKee, who started against the Panthers, will continue to assume quarterback duties as Hurts undergoes treatment and recovery. The Eagles face the challenge of maintaining offensive efficiency and leadership at the position while ensuring Hurts receives the necessary time to heal fully. This approach prioritizes Hurts’ career trajectory and long-term performance, aligning with best practices for medical clearance and athletic readiness.
Looking ahead, the team and medical staff will monitor Hurts with a focus on safety and gradual progression toward football activity. Medical decisions will weigh factors such as clot resolution, reduction of pulmonary emboli risk, and the patient’s response to anticoagulant therapy. If Hurts experiences improvement and clearance is granted, a careful reintroduction to football-related activities would follow, under close supervision and incremental steps to ensure a safe return.
In the meantime, Eagles supporters will be watching developments closely. The quarterback position is central to Philadelphia’s offensive identity, and substituting in the short term requires careful game planning and execution from the coaching staff. The organization will likely emphasize depth at the position, maintain a strategic balance in playcalling, and rely on the broader roster to keep the team competitive while Hurts focuses on his recovery.
Overall, the news marks a significant health challenge for a player who has been central to the Eagles’ offense. The emphasis remains on a full and safe recovery, with medical teams prioritizing Hurts’ well-being above all else. As the season progresses, updates on his condition and potential return will be highly anticipated, given the impact on team dynamics, game planning, and the broader championship ambitions for Philadelphia.
